IRIS
PECCI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.670
EU - Europa 2.793
AS - Asia 1.977
AF - Africa 12
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
Totale 8.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.635
CN - Cina 1.917
IE - Irlanda 977
UA - Ucraina 391
FI - Finlandia 378
IT - Italia 314
SE - Svezia 243
DE - Germania 221
GB - Regno Unito 136
FR - Francia 45
CA - Canada 29
BE - Belgio 22
IN - India 21
RU - Federazione Russa 17
RO - Romania 14
TR - Turchia 12
SG - Singapore 11
CH - Svizzera 10
MU - Mauritius 8
NL - Olanda 8
IR - Iran 7
CZ - Repubblica Ceca 6
JP - Giappone 6
PA - Panama 6
EU - Europa 4
NZ - Nuova Zelanda 4
AU - Australia 3
BR - Brasile 3
ES - Italia 3
ZA - Sudafrica 3
DK - Danimarca 2
PT - Portogallo 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
EG - Egitto 1
MD - Moldavia 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 8.467
Salva come PNG Salva come JPEG
Città #
Dublin 973
Chandler 833
Jacksonville 569
Nanjing 554
Ashburn 273
Nanchang 217
Princeton 197
Wilmington 197
Lawrence 180
Changsha 173
Beijing 172
Medford 163
Shenyang 157
Hebei 155
Jiaxing 126
Ann Arbor 102
Helsinki 95
Tianjin 89
Boardman 84
Hangzhou 75
Milan 75
Pavia 63
Shanghai 61
Woodbridge 53
New York 39
Houston 34
Verona 33
Norwalk 31
Fairfield 23
Brussels 22
Los Angeles 22
Pune 20
Auburn Hills 16
Falls Church 16
Toronto 16
Ningbo 15
Seattle 15
Zhengzhou 15
Jinan 14
Guangzhou 13
Taizhou 12
Timisoara 11
Des Moines 10
Rome 10
Zurich 8
Singapore 7
Washington 7
Brescia 6
Panama City 6
Rozzano 6
Tappahannock 6
Caccamo 5
Chongqing 5
Fuzhou 5
London 5
Orange 5
San Francisco 5
Tokyo 5
Ventura 5
Cincinnati 4
Dearborn 4
Hamilton 4
Lanzhou 4
Leeds 4
Palermo 4
Redwood City 4
Samsun 4
Tehran 4
Turin 4
Albany 3
Andover 3
Bari 3
Changchun 3
Dallas 3
Johannesburg 3
Kunming 3
Laives 3
Leawood 3
Moscow 3
Olomouc 3
Ottawa 3
Paceco 3
Phoenix 3
St Petersburg 3
Aprilia 2
Ardabil 2
Brighton 2
Brno 2
Casorate Sempione 2
Corsico 2
Desio 2
Geneva 2
Kemerovo 2
Liscate 2
Marcignago 2
Mariglianella 2
Melbourne 2
Montreal 2
Munich 2
Murcia 2
Totale 6.226
Salva come PNG Salva come JPEG
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 101
Cochlear implantation is safe and effective in patients with MYH9-related disease. 90
MYH9-Related Disorders. 90
A case of phagocytic multiple myeloma 83
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle. 82
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 79
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 77
Spectrum of the mutations in Bernard-Soulier syndrome. 77
A qualitative and quantitative cytochemical assay of dihydrofolate reductase in megakariocytes of patients with 5q-syndrome. 76
Dihydrofolate reductase activity in the erythroblasts of patients with 5q-syndrome. 74
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. 73
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 72
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 72
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 71
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 71
Bone marrow necrosis in acute lymphoblastic leukemia. 69
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 69
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 68
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 68
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 66
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 66
A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia. 64
Lessons in platelet production from inherited thrombocytopenias. 64
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 64
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 63
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 63
A case of metastatic malignant melanoma with bone marrow involvement. 63
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 62
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 62
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17. 61
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 61
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 61
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 61
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 61
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 61
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow. 60
Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome. 60
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 60
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 59
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 58
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 58
Inherited thrombocytopenias. The evolving spectrum. 58
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 58
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 58
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 57
International prognostic scoring system (IPSS) and other prognostic systems for myelodysplastic syndromes (MDS). 57
The Case. Proteinuria and low platelet count. 57
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 57
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 57
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 57
Expression, activation and subcellular localization of the Rap1 GTPase in human cord blood-derived megakaryocytes 56
Chaperone molecules concentrate together with the ubiquitin–proteasome system inside particulate cytoplasmic structures: possible role in metabolism of misfolded proteins 56
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 56
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives. 55
Low-dose thalidomide ameliorates cytopenia and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II clinical trial. 55
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia. 55
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 55
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 55
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 54
ANKRD26-related thrombocytopenia and myeloid malignancies 54
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 54
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). 53
Von Willebrand Factor and GPIb regulates proplatelets formation by human megakaryocytes. 53
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 53
Gene expression profiling of megakaryocytes from human cord blood. 53
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 53
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 53
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes. 52
Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists. 52
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 52
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 52
5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia 52
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 52
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes 51
Micromegakaryocytic transformation of myelofibrosis with myeloid metaplasia. 51
Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia. 51
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 51
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 51
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 51
Reduced expression of CXCR4 on circulating CD34+ cells is associated with hematopoietic progenitor cells (HPC) mobilization in patients with myelofibrosis with myeloid metaplasia (MMM). 50
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 50
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 50
The european hematology association roadmap for european hematology research: A consensus document 50
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 50
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 49
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 49
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 49
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle 48
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 48
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 48
Cutaneous involvement by post-polycythemia vera myelofibrosis. 48
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 48
Inherited thrombocytopenias—recent advances in clinical and molecular aspects 48
Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome. 48
Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: Relevance for MYH9-related disease. 48
null 47
Diagnostic assessment of macrothrombocytopenia and the place of MYH9 mutation screening 47
Evaluation of cytokines mobilizing hematopoietic progenitor cells in patients with myelofibrosis with myeloid metaplasia (MMM) 47
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 47
Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. 47
Totale 5.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.117 664 909 3 72 1 82 36 82 14 163 84 7
2020/2021891 94 76 31 74 5 100 6 145 87 126 116 31
2021/2022866 15 1 21 14 38 29 26 47 49 39 122 465
2022/20232.484 265 165 14 215 237 250 2 125 1.097 12 67 35
2023/20241.020 96 166 25 81 161 237 55 54 8 50 45 42
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 8.898